Diabetes Treatment Drugs Market Overview
The Diabetes Treatment Drugs Market was valued at $70 billion in 2024 and is projected to reach $90 billion by 2035, growing at a CAGR of 2.3%. This market encompasses insulin, sulfonylureas, DPP-4 inhibitors, GLP-1 receptor agonists, and meglitinides, each addressing different patient needs across Type 1, Type 2, and gestational diabetes. Rising global diabetes prevalence, driven by obesity...
0 Comments 0 Shares 96 Views 0 Reviews